⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
GH News
Guardant Health, Inc. Common Stock
Companion Diagnostics Market worth $11.57 billion by 2031 | MarketsandMarkets™
prnewswire.com
AGNC
TMO
GH
DHR
ABT
ILMN
MYGN
DGX
CRSP
NVDA
Chase Scolnick and Kay Anderle Recognized by Chambers USA 2026 as Keller Anderle Scolnick LLP Earns Band 1 Ranking in California Commercial Litigation
prnewswire.com
GH
Liquid Biopsy Market to Surpass USD 36.78 Billion by 2035 as Precision Oncology and Cancer Diagnostics Drive Growth – SNS Insider
globenewswire.com
GH
NTRA
Guardant Health and Collaborators to Present 38 Abstracts Highlighting Breadth and Expanded Clinical Utility of Guardant Liquid Biopsy Tests Powered by InfinityAI at 2026 ASCO Annual Meeting
businesswire.com
GH
FDA Approves New Guardant360 Liquid CDx, the Largest FDA-Approved Liquid Biopsy Panel with a 100x Expanded Footprint
businesswire.com
GH
Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
GH
AI and Advanced Diagnostics Transform Cancer Detection Market Amid Rising Healthcare Investment
globenewswire.com
EXAS
GH
ILMN
DHR
TMO
ABT
Plug and Play backs first 6 Albanian startups, signaling country's emerging tech ecosystem
prnewswire.com
GH
LC
PYPL
Global Liquid Biopsy Market Projected to Hit USD 7.05 Billion by 2030 | MarketsandMarkets™
globenewswire.com
NTRA
GH
MYGN
ILMN
QGEN
TMO
BIO
EXAS
INV
Pancreatic Cancer Diagnostics Research Report 2026
globenewswire.com
NVDA
AIM
ILMN
GH